These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Spencker S; Coban N; Koch L; Schirdewan A; Müller D Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654 [TBL] [Abstract][Full Text] [Related]
7. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure. Gunderson BD; Gillberg JM; Wood MA; Vijayaraman P; Shepard RK; Ellenbogen KA Heart Rhythm; 2006 Feb; 3(2):155-62. PubMed ID: 16443529 [TBL] [Abstract][Full Text] [Related]
8. Inappropriate discharges of intravenous implantable cardioverter defibrillators owing to lead failure. Washizuka T; Chinushi M; Kazama R; Hirono T; Watanabe H; Komura S; Sugiura H; Tanabe Y; Furushima H; Fujita S; Okura Y; Aizawa Y Int Heart J; 2005 Sep; 46(5):909-13. PubMed ID: 16272782 [TBL] [Abstract][Full Text] [Related]
9. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing. Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead. Kitamura S; Satomi K; Kurita T; Shimizu W; Suyama K; Aihara N; Niwaya K; Kobayashi J; Kamakura S Circ J; 2006 Mar; 70(3):273-7. PubMed ID: 16501292 [TBL] [Abstract][Full Text] [Related]
11. Insulation defects in Riata implantable cardioverter-defibrillator leads. Sato A; Chinushi M; Iijima K; Izumi D; Furushima H Intern Med; 2012; 51(19):2689-94. PubMed ID: 23037457 [TBL] [Abstract][Full Text] [Related]
12. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management. Olde Nordkamp LR; Brouwer TF; Barr C; Theuns DA; Boersma LV; Johansen JB; Neuzil P; Wilde AA; Carter N; Husby M; Lambiase PD; Knops RE Int J Cardiol; 2015 Sep; 195():126-33. PubMed ID: 26026928 [TBL] [Abstract][Full Text] [Related]
13. Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study. Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Sachanandani H; Ellenbogen KA Circulation; 2010 Oct; 122(15):1449-55. PubMed ID: 20876433 [TBL] [Abstract][Full Text] [Related]
14. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience. Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684 [TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter-defibrillator lead failure in children and young adults: a matter of lead diameter or lead design? Janson CM; Patel AR; Bonney WJ; Smoots K; Shah MJ J Am Coll Cardiol; 2014 Jan; 63(2):133-40. PubMed ID: 24140671 [TBL] [Abstract][Full Text] [Related]
16. Lead Integrity Alert Is Useful for Assessment of Performance of Biotronik Linox Leads. Steinberg C; Padfield GJ; Hahn E; Flavelle S; McILROY C; VAN Bremen O; Yeung-Lai-Wah JA; Kerr CR; Deyell MW; Tung SK; Andrade JG; Bennett MT; Bashir JG; Krahn AD; Chakrabarti S J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1340-5. PubMed ID: 26471861 [TBL] [Abstract][Full Text] [Related]
17. Spectrum of issues detected by an ICD diagnostic alert that utilizes far-field electrograms: Clinical implications. Koneru JN; Kaszala K; Bordachar P; Shehata M; Swerdlow C; Ellenbogen KA Heart Rhythm; 2015 May; 12(5):957-67. PubMed ID: 25640632 [TBL] [Abstract][Full Text] [Related]
18. Sensing lead failure in implantable defibrillators: a comparison of two commonly used leads. Degeratu FT; Khalighi K; Peters RW; Shorofsky SR; Gold MR J Cardiovasc Electrophysiol; 2000 Jan; 11(1):21-4. PubMed ID: 10695456 [TBL] [Abstract][Full Text] [Related]